XML 33 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Convertible Preferred Stock, Redeemable Common Stock and Stockholders' Equity (Deficit) - USD ($)
Total
IPO
Private Placement
Warrants issued in conjunction with series A preferred stock
Issued to placement agents
Issued for services
Issued in connection with IPO
Series A Preferred Stock
Series Seed Preferred Stock
Redeemable Common Stock
Common stock
Common stock
IPO
Common stock
Private Placement
Common stock
Issued in connection with IPO
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Additional Paid-in Capital
Private Placement
Additional Paid-in Capital
Warrants issued in conjunction with series A preferred stock
Additional Paid-in Capital
Issued to placement agents
Additional Paid-in Capital
Issued for services
Additional Paid-in Capital
Issued in connection with IPO
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2019               0 0 16,666                        
Beginning balance at Dec. 31, 2019               $ 0 $ 0 $ 126,000                        
Increase (Decrease) in Temporary Equity [Roll Forward]                                            
Temporary equity new shares issued (in shares)               132,537 8,771                          
Temporary equity new shares issued               $ 950,000 $ 50,000                          
Conversion of convertible securities (in shares)               78,178 2,615,553                          
Conversion of convertible securities               $ 529,902 $ 6,291,288                          
Fair value of warrants issued in conjunction with the Series A preferred stock               $ (78,967)                            
Change in fair value of redeemable common stock to redemption value                   $ (97,000)                        
Ending balance (in shares) at Dec. 31, 2020               210,715 2,624,324 16,666                        
Ending balance at Dec. 31, 2020 $ 7,771,223             $ 1,400,935 $ 6,341,288 $ 29,000                        
Beginning balance (in shares) at Dec. 31, 2019                     324,145                      
Beginning balance at Dec. 31, 2019 (23,960,756)                   $ 324       $ 1,480,955             $ (25,442,035)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Fair value of warrants issued in conjunction with the Series A preferred stock       $ 78,967                           $ 78,967        
Share-based compensation expense, including vesting of restricted stock and issuance of common stock (in shares)                     7,644                      
Share-based compensation expense, including vesting of restricted stock and issuance of common stock 219,245                   $ 8       219,237              
Change in fair value of redeemable common stock to redemption value 97,000                           97,000              
Net (loss) income 6,644,465                                         6,644,465
Ending balance (in shares) at Dec. 31, 2020                     331,789                      
Ending balance at Dec. 31, 2020 (16,921,079)                   $ 332       1,876,159             (18,797,570)
Increase (Decrease) in Temporary Equity [Roll Forward]                                            
Temporary equity new shares issued (in shares)               738,445                            
Temporary equity new shares issued               $ 4,982,835                            
Conversion of convertible securities (in shares)               844,824                            
Conversion of convertible securities               $ 5,728,793                            
Temporary equity, stock issued for services (in shares)               418,559                            
Temporary equity, stock issued for services               $ 2,837,832                            
Fair value of warrants issued in conjunction with the Series A preferred stock               (265,593)                            
Fair value of warrants issued as placement agent fees               $ (43,797)                            
Change in fair value of redeemable common stock to redemption value                   $ 53,330                        
Conversion of convertible preferred shares and redeemable common shares upon initial public offering (in shares)               (2,212,543) (2,624,324) (16,666)                        
Conversion of convertible preferred shares and redeemable common shares upon initial public offering               $ (14,641,005) $ (6,341,288) $ (82,330)                        
Ending balance (in shares) at Dec. 31, 2021               0 0 0                        
Ending balance at Dec. 31, 2021 0             $ 0 $ 0 $ 0                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Fair value of warrants issued in conjunction with the Series A preferred stock       $ 265,593 $ 43,797 $ 371,895                       $ 265,593 $ 43,797 $ 371,895    
Share-based compensation expense, including vesting of restricted stock and issuance of common stock (in shares)                     20,915                      
Share-based compensation expense, including vesting of restricted stock and issuance of common stock 511,079                   $ 21       511,058              
Conversion of convertible securities (in shares)                           9,816                
Conversion of convertible securities 137,497           $ 0             $ 10 137,497           $ (10)  
Conversion of convertible preferred shares and redeemable common shares upon initial public offering (in shares)                     4,853,533                      
Conversion of convertible preferred shares and redeemable common shares upon initial public offering 21,064,623                   $ 4,853       21,059,770              
Change in fair value of redeemable common stock to redemption value (53,330)                           (53,330)              
Sale of common stock in initial public offering, net of issuance costs (in shares)                       5,750,000 5,000,000                  
Stock Issued During Period, Value, Initial Public Offering   $ 24,428,626 $ 28,880,504                 $ 5,750 $ 5,000     $ 24,422,876 $ 28,875,504          
Net (loss) income (10,456,870)                                         (10,456,870)
Ending balance (in shares) at Dec. 31, 2021                     15,966,053                      
Ending balance at Dec. 31, 2021 $ 48,272,335                   $ 15,966       $ 77,510,809             $ (29,254,440)